This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Nutriband, Inc.. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: Innovations by Jeffrey C. Gaulding
Introduction
Jeffrey C. Gaulding is an accomplished inventor based in Peachtree Corners, GA (US). He has made significant contributions to the field of transdermal delivery systems, particularly focusing on abuse and misuse deterrent technologies. With a total of 3 patents to his name, Gaulding's work addresses critical issues in drug safety and efficacy.
Latest Patents
One of Gaulding's notable patents is the development of an abuse and misuse deterrent transdermal patch. This innovative patch incorporates aversive agents within its backing layer. The aversive agents are designed to exhibit biphasic or sustained kinetics of release. An immediate portion is released rapidly, while an extended portion is released in a prolonged manner when exposed to a dissolution medium. This dual-release mechanism provides a deterrent against the extraction of drugs from both fresh and used patches. It also serves to prevent accidental misuse of used patches by children. The patch systems are particularly beneficial for the transdermal delivery of therapeutically active agents, especially those drugs that are highly prone to abuse, such as opiate and opioid analgesics and stimulants.
Career Highlights
Throughout his career, Gaulding has worked with several companies, including Nutriband, Inc. and 4P Therapeutics. His experience in these organizations has allowed him to refine his expertise in developing innovative solutions for drug delivery systems.
Collaborations
Some of Gaulding's notable coworkers include Steven Paul Damon and Frank Tagliaferri. Their collaborative efforts have contributed to the advancement of technologies in the pharmaceutical field.
Conclusion
Jeffrey C. Gaulding's innovative work in the development of abuse and misuse deterrent transdermal systems highlights his commitment to improving drug safety. His contributions are essential in addressing the challenges associated with drug abuse and ensuring the effective delivery of therapeutically active agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile